These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25343294)

  • 1. Comparative efficacy and bioequivalence of novel h1-antihistamine bepotastine salts (nicotinate and salicylate).
    Lim DS; Youn YS; Kwack SJ; Kwak HM; Lim SK; Kim JY; Um YM; Lee JD; Hyeon JH; Kim YJ; Kim HS; Lee BM
    J Toxicol Environ Health A; 2014; 77(22-24):1451-66. PubMed ID: 25343294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel bepotastine salicylate salt bioequivalent to the commercial bepotastine besilate in beagle dogs.
    Cho KH; Choi HG
    Drug Dev Ind Pharm; 2013 Jun; 39(6):901-8. PubMed ID: 22963365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic comparisons of bepotastine besilate and bepotastine salicylate in healthy subjects.
    Kim KA; Park JY
    Clin Drug Investig; 2013 Dec; 33(12):913-9. PubMed ID: 24105252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate release tablet formulation of varenicline salicylate and comparative pharmacokinetic study in human volunteers.
    Kwak SS; Lee ES; Yoon HY; Kim CH; Goo YT; Kang MJ; Lee S; Lee BS; Jeon HR; Oh CH; Choi YW
    Drug Des Devel Ther; 2018; 12():3377-3392. PubMed ID: 30349192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate.
    Williams JI; Gow JA; Klier SM; McCue SL; Salapatek AM; McNamara TR
    Curr Med Res Opin; 2010 Oct; 26(10):2329-38. PubMed ID: 20735291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel prasugrel base microsphere-loaded tablet with enhanced stability: Physicochemical characterization and in vivo evaluation in beagle dogs.
    Kim KS; Kim JC; Jin SG; Kim DW; Kim DS; Yong CS; Kim JO; Youn YS; Oh KT; Woo JS; Choi HG
    Colloids Surf B Biointerfaces; 2016 Oct; 146():754-61. PubMed ID: 27451362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel fenofibric acid-loaded controlled release pellet bioequivalent to choline fenofibrate-loaded commercial product in beagle dogs.
    Kim KS; Jin SG; Mustapha O; Yousaf AM; Kim DW; Kim YH; Kim JO; Yong CS; Woo JS; Choi HG
    Int J Pharm; 2015 Jul; 490(1-2):273-80. PubMed ID: 26024820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate.
    Ohashi R; Kamikozawa Y; Sugiura M; Fukuda H; Yabuuchi H; Tamai I
    Drug Metab Dispos; 2006 May; 34(5):793-9. PubMed ID: 16455807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bepotastine besilate for the treatment of pruritus.
    Bielory L; Duttachoudhury S; McMunn A
    Expert Opin Pharmacother; 2013 Dec; 14(18):2553-69. PubMed ID: 24191914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel tenofovir disoproxil phosphate salt with stability enhancement and bioequivalence to the commercial tenofovir disoproxil fumarate salt in rats and beagle dogs.
    Cho JH; Choi HG
    Int J Pharm; 2020 Feb; 576():118957. PubMed ID: 31843551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New clopidogrel napadisilate salt and its solid dispersion with improved stability and bioequivalence to the commercial clopidogrel bisulphate salt in beagle dogs.
    Kim YI; Kim KS; Suh KH; Shanmugam S; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2011 Aug; 415(1-2):129-39. PubMed ID: 21645599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
    Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
    Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression by bepotastine besilate of substance P-induced itch-associated responses through the inhibition of the leukotriene B4 action in mice.
    Andoh T; Kuraishi Y
    Eur J Pharmacol; 2006 Oct; 547(1-3):59-64. PubMed ID: 16914135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge.
    Torkildsen GL; Williams JI; Gow JA; Gomes PJ; Abelson MB; McNamara TR;
    Ann Allergy Asthma Immunol; 2010 Jul; 105(1):57-64. PubMed ID: 20642205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve. A single-center, single-dose, randomized, open-label, 2-way crossover study under fasting conditions.
    Almeida S; Filipe A; Neves R; Desjardins I; Shink E; Castillo A
    Arzneimittelforschung; 2010; 60(3):116-23. PubMed ID: 20422942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UPLC-MS/MS method for determination of bepotastine in human plasma.
    Choi YK; Chung YH; Nam YS; Kang DY; Kim H; Lee SE; Kim HR; Lee YS; Jeong JH
    J Chromatogr Sci; 2014 Sep; 52(8):886-93. PubMed ID: 24023058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet.
    Cho JH; Kim YI; Kim DW; Yousaf AM; Kim JO; Woo JS; Yong CS; Choi HG
    Eur J Pharm Sci; 2014 Apr; 54():1-7. PubMed ID: 24388864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence evaluation of two brands of lisinopril tablets by in vitro comparative dissolution test and in vivo bioequivalence test.
    Shin MC; Kim JK; Kim CK
    Arzneimittelforschung; 2008; 58(1):11-7. PubMed ID: 18368945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.